Pain Physician is a premier journal that plays a critical role in the field of anesthesiology and pain medicine, published by the American Society of Interventional Pain Physicians. With an impressive impact factor and ranked in the Q1 category of Scopus for its significant contributions to the literature, the journal has established itself as a leading source of innovative research and clinical insights since its inception in 1999. Covering a wide array of topics related to pain management, the journal aims to disseminate high-quality studies that inform best practices and enhance patient care. As a well-respected publication, Pain Physician offers essential access to the latest developments and methodologies in pain therapy to researchers, clinicians, and students alike, fostering a deeper understanding of this critical area of medicine. With its commitment to advancing research and practice, Pain Physician is an invaluable resource for those dedicated to improving the quality of life for individuals suffering from chronic pain.

Pain Management Nursing is a premier journal dedicated to advancing the field of pain management through rigorous research and practical insights. Published by Elsevier Science Inc., this esteemed journal holds a Q1 ranking in Advanced and Specialized Nursing as of 2023, highlighting its significance in the academic and clinical nursing community. With an impressive Scopus rank of #11 out of 63 in its category, Pain Management Nursing presents a platform for researchers, clinicians, and educators to disseminate and access high-quality articles focused on pain assessment, treatment modalities, and evidence-based practice. The journal is published in the United States and covers a wide array of topics from innovative pain management strategies to interdisciplinary approaches. By fostering critical discourse and facilitating knowledge exchange, this journal plays a vital role in improving patient outcomes in pain management. Be part of this influential publication's journey from 2000 through 2024, as it continues to shape the future of nursing in this essential specialization.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, published by Taylor & Francis Inc, is a vital resource for professionals in the fields of anesthesiology, pain medicine, and pharmacology. With an ISSN of 1536-0288 and an E-ISSN of 1536-0539, this esteemed journal has been providing a platform for innovative research and critical reviews since its inception in 2002, and it will continue to contribute to scientific discourse until 2024. Holding a Q2 ranking in Anesthesiology and Pain Medicine and a Q3 ranking in Medical Pharmacology, the journal is positioned to deliver high-impact articles that explore advancements in pain management and palliative care strategies. While not an Open Access journal, it offers significant subscription-based access to its curated content, ensuring that researchers and practitioners have the opportunity to stay updated on the latest trends and findings in pain therapy. Furthermore, with its Scopus rankings reflecting ongoing relevance and a robust academic community, this journal is essential for those aiming to deepen their understanding of pain management pharmacotherapy.

REGIONAL ANESTHESIA AND PAIN MEDICINE, published by the BMJ Publishing Group, stands at the forefront of publishing innovative research and advancements in the fields of anesthesiology and pain management. Since its inception in 1998, this journal has become an essential resource for clinicians, researchers, and students, featuring insightful articles that span basic research, clinical trials, and reviews, all aimed at improving patient outcomes. With an impressive impact factor and ranking as a Q1 journal in both Anesthesiology and Pain Medicine, as well as a ranking of #11 out of 136 in Scopus, it showcases some of the most significant contributions to the discipline. The journal's commitment to disseminating high-quality, peer-reviewed content underlines its integral role in enhancing clinical practices, educating professionals, and shaping future research directions. As an open-access journal, it ensures that critical findings are accessible to a global audience, further promoting its mission to advance health care practices across various settings.

NEUROMODULATION is a premier academic journal dedicated to advancing the fields of anesthesiology, pain medicine, and neurology. Published by Elsevier, this prestigious journal has consistently maintained a high impact factor, reflecting its relevance and influence in the medical community. With a commendable track record spanning from 1998 to 2024, NEUROMODULATION is classified in the Q1 quartile for both Anesthesiology and Pain Medicine and Medicine (miscellaneous), demonstrating its excellence among top-tier journals. Additionally, it ranks in the Q2 quartile for Neurology and Clinical Neurology, showcasing a broad appeal across multiple disciplines. The journal's substantial Scopus rankings—22nd out of 136 in Anesthesiology and Pain Medicine and 93rd out of 400 in Clinical Neurology—underscore its critical role in disseminating cutting-edge research and clinical findings. NEUROMODULATION endeavors to provide a robust platform for researchers, clinicians, and students to explore innovative therapeutic approaches and the complexities of neural modulation, ultimately contributing to improved patient outcomes and advancing the state of medical science.

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.

Journal of Oral & Facial Pain and Headache is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of orofacial pain and headache disorders. Published by QUINTESSENCE PUBLISHING CO INC in the United States, this journal serves as a critical resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and dentistry. With a commendable impact factor reflected in its 2023 rankings—Q1 in Dental (miscellaneous) and Q2 in both Anesthesiology & Pain Medicine and Clinical Neurology—this journal highlights cutting-edge research and innovative practices aimed at improving patient outcomes. The journal's content is accessible with an Open Access option, ensuring that significant findings reach a broad audience. Since its inception in 1993 and through its evolving scope, Journal of Oral & Facial Pain and Headache remains an indispensable platform for scholarly exchange and professional development in its specialized field.

The European Journal of Pain, published by Wiley, is a premier peer-reviewed journal specializing in the fields of Anesthesiology and Pain Medicine. With an impressive impact factor and a prestigious ranking in the Q1 category for both Anesthesiology and Pain Medicine, as well as Miscellaneous Medicine, this journal stands out in the academic landscape, significantly contributing to the understanding and treatment of pain across various patient populations. Operating since 1997 and continuing through 2024, the journal provides a platform for groundbreaking research, reviews, and clinical studies, making it an invaluable resource for researchers, practitioners, and students alike. While it operates under a subscription model, the rigorous peer-review process ensures that readers access high-quality, evidence-based content that is essential for the advancement of pain management and anesthetic practices globally.

PAIN MEDICINE, published by Oxford University Press, is a leading journal in the disciplines of Anesthesiology and Pain Medicine. With its ISSN 1526-2375 and E-ISSN 1526-4637, this esteemed journal provides a platform for innovative research and clinical advancements in the field of pain management. With an impressive impact factor attributed to its Q1 ranking in both Anesthesiology and Pain Medicine as well as Q2 in Clinical Neurology for 2023, PAIN MEDICINE ensures high visibility and relevance within the scientific community, noted for its diverse contributions from across the globe. The journal's editorial mission focuses on disseminating significant findings that influence contemporary practices and policies in pain management. Scholars and practitioners are encouraged to engage with this vital resource, which shapes the future of pain medicine from its base at Great Clarendon St, Oxford, England, covering a remarkable timeline from 2000 to 2024.